11-124750839-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014312.5(VSIG2):c.302T>A(p.Val101Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014312.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG2 | NM_014312.5 | c.302T>A | p.Val101Glu | missense_variant | 3/7 | ENST00000326621.10 | NP_055127.2 | |
VSIG2 | NM_001329920.2 | c.302T>A | p.Val101Glu | missense_variant | 3/6 | NP_001316849.1 | ||
VSIG2 | XM_047426684.1 | c.302T>A | p.Val101Glu | missense_variant | 3/5 | XP_047282640.1 | ||
VSIG2 | XM_047426685.1 | c.62-973T>A | intron_variant | XP_047282641.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG2 | ENST00000326621.10 | c.302T>A | p.Val101Glu | missense_variant | 3/7 | 1 | NM_014312.5 | ENSP00000318684.5 | ||
VSIG2 | ENST00000403470.1 | c.302T>A | p.Val101Glu | missense_variant | 3/6 | 2 | ENSP00000385013.1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000717 AC: 18AN: 251066Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135816
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461802Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 727184
GnomAD4 genome AF: 0.000237 AC: 36AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2022 | The c.302T>A (p.V101E) alteration is located in exon 3 (coding exon 3) of the VSIG2 gene. This alteration results from a T to A substitution at nucleotide position 302, causing the valine (V) at amino acid position 101 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at